Chinese Journal of Cancer - CJC 《癌症》杂志

pISSN: 1000-467X

eISSN: 1944-446X

CN: 44-1195/R

View OnlineFirst Articles

New articles accepted recently

View Current Issue

Volume 36 Issue 6

Browse Past Issues

From January 2002

In this issue

The most 150 important questions in cancer research and clinical oncology.

Immunological effect of local ablation combined with immunotherapy on solid malignancies

Prognostic value of CD30 expression in extranodal natural killer/T-cell lymphoma

CJC's SCI Impact Factor reaches 4.111 in 2016

Chinese Journal of Cancer is collecting 150 most important questions in cancer research and clinical oncology

Chinese Journal of Cancer连续三年入选“中国最具国际影响力学术期刊”

The 4th Guangzhou International Symposium on Oncology Held

We are pleased to announce that the first Impact Factor of CJC is 2.155

U.S. Chinese Anti-Cancer Association-Asia Fund for Cancer Research 2015 Scholar Awards

巧用PowerPoint制作和修改医学论文图片——编辑部业务学习会整理

The New Horizons in Cancer Research Conference of AACR ended successfully in Shanghai

The Chinese Journal of Cancer is indexed in Science Citation Index (SCI) Expanded

Four outstanding young Chinese scientists received the 2013 Scholar Award from the US Chinese Anti-Cancer Association and the National Foundation for Cancer Research

CJC wins the title of the 2012' Excellent International Impact Academic Journal of China

Special Feature: Five outstanding young Chinese scholars received the Third Scholar Award from the Asian Fund for Cancer Research (AFCR) and the US Chinese Anti-Cancer Association (USCACA)

1 Low expression of centrosomal protein 78 (CEP78) is associated with poor prognosis of colorectal cancer patients

Meifang Zhang, Tingmei Duan, Li Wang, Jianjun Tang, Rongzhen Luo, Ruhua Zhang and Tiebang Kang

[ Abstract ] [ PDF Full-text ] [ PubMed] 2016-10 Downloaded: 1411

2 Attenuated LKB1-SIK1 signaling promotes epithelial-mesenchymal transition and radioresistance of non–small cell lung cancer cells

Yuan-Hu Yao, Yan Cui, Xiang-Nan Qiu, Long-Zhen Zhang, Wei Zhang, Hao Li and Jin-Ming Yu

[ Abstract ] [ PDF Full-text ] [ PubMed] 2016-10 Downloaded: 1331

3 Chromatin remodeling factor LSH affects fumarate hydratase as a cancer driver

Shuang Liu and Yong-Guang Tao

[ Abstract ] [ PDF Full-text ] [ PubMed] 2016-10 Downloaded: 1011

4 Chemotherapy in non-small cell lung cancer: opportunities for advancement

Mani Akhtari, Eric H. Bernicker and Bin S. Teh

[ Abstract ] [ PDF Full-text ] [ PubMed] 2016-9 Downloaded: 1210

5 Cell-free circulating tumor DNA in cancer

Zhen Qin, Vladimir A. Ljubimov, Cuiqi Zhou, Yunguang Tong and Jimin Liang

[ Abstract ] [ PDF Full-text ] [ PubMed] 2016-5 Downloaded: 3030

6 Altered expression of stromal interaction molecule (STIM)-calcium release-activated calcium channel protein (ORAI) and inositol 1,4,5-trisphosphate receptors (IP3Rs) in cancer: will they become a new battlefield for oncotherapy?

Jing Wen, Ying-Cheng Huang, Huan-Huan Xiu, Zhi-Ming Shan and Kang-Qing Xu

[ Abstract ] [ PDF Full-text ] [ PubMed] 2016-5 Downloaded: 3399

1 The US Chinese Anti-Cancer Association and the National Foundation for Cancer Research recognize five young Chinese investigators with the 2014 USCACA-NFCR Scholar Awards

Wei Zhang, Lifang Hou, Li Yan, Wei Zhang, Michael Yi Wang, Shi-Yuan Cheng

[ Abstract ] [ PDF Full-text ] [ PubMed] 2014-11 Downloaded: 6222

2 Mechanisms of vascularization in murine models of primary and metastatic tumor growth

Edina Bugyik, Ferenc Renyi-Vamos, Vanessza Szabo, Katalin Dezso, Nora Ecker, Andras Rokusz, Peter Nagy, Balazs Dome and Sandor Paku

[ Abstract ] [ PDF Full-text ] [ PubMed] 2016-2 Downloaded: 5080

3 Trabectedin therapy as an emerging treatment strategy for recurrent platinum-sensitive ovarian cancer

José Antonio López-Guerrero, Ignacio Romero, Andrés Poveda

[ Abstract ] [ PDF Full-text ] [ PubMed] 2015-1 Downloaded: 4817

4 Ovarian cancer standard of care: are there real alternatives?

Chiara Della Pepa, Giuseppe Tonini, Carmela Pisano, Marilena Di Napoli, Sabrina Chiara Cecere, Rosa Tambaro, Gaetano Facchini, Sando Pignata

[ Abstract ] [ PDF Full-text ] [ PubMed] 2015-1 Downloaded: 4130

5 Immune checkpoint inhibitors in clinical trials

Elad Sharon, Howard Streicher, Priscila Goncalves, Helen X.Chen

[ Abstract ] [ PDF Full-text ] [ PubMed] 2014-9 Downloaded: 3791

Gastric cancer 　

Edited by Yun Dai and Li Yan
　

This thematic series discusses the molecular classifications of gastric cancer by the Cancer Genome Atlas (TCGA) and the Asian Cancer Research Group (ACRG) as well as the implications in personalized therapeutic choices; discusses the evolution of gastric surgery and presents perspectives on surgical techniques in treating gastric cancer; and reviews current and emerging targeted agents as well as immunotherapies in treating gastric cancer. With these advancements in molecular characterization, surgical intervention, and targeted and immunotherapies, gastric cancer will enter a personalized medicine era in the next 5 years.

Read thematic series >　

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -　

Tumor angiogenesis 　

Edited by Francesco Pezzella
and Chao-Nan Qian　

Forming efficient vasculature network, also known as tumor angiogenesis, is a critical hallmark in tumor development. Explorations on its underlying molecular mechanisms have resulted in several novel anti-cancer drugs. However, the modest survival benefits from anti-angiogenic therapy have forced us to revisit our understanding on tumor angiogenesis. In this special issue, world-leading experts have contributed their critical thoughts to reveal alternative tumor angiogenesis approaches and potential treatment targets.

Read thematic series >　

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -　

Lung cancer　

Edited by Lin Yan and Wei Zhang 　

Lung cancer accounts for approximately 21% of worldwide cancer deaths and a staggering 1.6 million new cases are diagnosed every year. In China, lung cancer has become a particularly challenging disease because of air pollution and smoking. This thematic series discusses the proper use of targeted agents in treating lung cancer, reviews the application of biomarkers in clinical management and drug development, and analyzes the unique challenges in developing novel drugs for lung cancer in China.

Read thematic series >　